US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

US IPOs and Secondary Offerings

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>AEVEX Aerospace launched its IPO, offering 16M shares at $18–$21, implying a ~$2.0B–$2.35B valuation ahead of April 17 debut.</li>
<li>Backed by Madison Dearborn Partners, which will retain ~79% voting control post-IPO, highlighting a typical private equity-led public exit structure.</li>
<li>Proceeds (~$278M) will fund unit purchases to streamline ownership, while strong defense sector tailwinds may offset modest revenue growth and attract investor demand.</li>
</ul>


AEVEX Aerospace launched its IPO, offering 16M shares at $18–$21, implying a ~$2.0B–$2.35B valuation ahead of April 17 debut.
Backed by Madison Dearborn Partners, which will retain ~79% voting control post-IPO, highlighting a typical private equity-led public exit structure.
Proceeds (~$278M) will fund unit purchases to streamline ownership, while strong defense sector tailwinds may offset modest revenue growth and attract investor demand.


AEVEX Corp (AVEX): PE-Backed Defense Technology Company Sets Terms Seeking up to $2.35b Valuation

<ul>
<li>AEVEX Aerospace filed for IPO, signaling strong momentum across space and defense listings.</li>
<li>AEVEX is a scaled UxS/ISR platform with proven battlefield deployment, 10K+ systems delivered/committed, and deep ties to U.S. defense and intelligence agencies.</li>
<li>Backed by Madison Dearborn Partners, AEVEX targets a rapidly expanding multi-billion-dollar autonomous defense market with significant growth and IPO investor appeal.v</li>
</ul>


AEVEX Aerospace filed for IPO, signaling strong momentum across space and defense listings.
AEVEX is a scaled UxS/ISR platform with proven battlefield deployment, 10K+ systems delivered/committed, and deep ties to U.S. defense and intelligence agencies.
Backed by Madison Dearborn Partners, AEVEX targets a rapidly expanding multi-billion-dollar autonomous defense market with significant growth and IPO investor appeal.v


Aevex Corp (AVEX): Peeking at the IPO Prospectus of a PE-Backed Defense Technology Company

<ul>
<li>Hawkeye 360 is launching a 16mm share IPO at $24–$26 ($2.2–$2.4bn market cap) on May 7, backed by top-tier underwriters in a strong defense-tech issuance window.</li>
<li>The company operates a satellite-based SIGINT platform with 30+ satellites, delivering RF intelligence to U.S. and allied governments, enhanced by ISA acquisition enabling classified signal processing integration.</li>
<li>Revenue grew 74% to $117.7mm in 2025 with a $302.7mm funded backlog, supporting recurring revenue visibility and positioning it as a high-growth national security data platform.</li>
</ul>


Hawkeye 360 is launching a 16mm share IPO at $24–$26 ($2.2–$2.4bn market cap) on May 7, backed by top-tier underwriters in a strong defense-tech issuance window.
The company operates a satellite-based SIGINT platform with 30+ satellites, delivering RF intelligence to U.S. and allied governments, enhanced by ISA acquisition enabling classified signal processing integration.
Revenue grew 74% to $117.7mm in 2025 with a $302.7mm funded backlog, supporting recurring revenue visibility and positioning it as a high-growth national security data platform.


HawkEye 360 Inc. (HAWK): Defense Technology Partner of USA Sets Terms for IPO

Kailera Therapeutics / Equity Capital Markets

<ul>
<li>Kailera Therapeutics IPO demand is multiple-times oversubscribed, signaling strong institutional interest and potential pricing strength ahead of its expected Friday debut.</li>
<li>Lead asset ribupatide in Phase 3 targets best-in-class weight loss, supported by a diversified GLP-1 pipeline spanning oral and injectable therapies.</li>
<li>Backed by top-tier investors and led by a proven CEO with major biotech exits, positioning the company for strong execution and potential long-term value creation.</li>
</ul>


Kailera Therapeutics IPO demand is multiple-times oversubscribed, signaling strong institutional interest and potential pricing strength ahead of its expected Friday debut.
Lead asset ribupatide in Phase 3 targets best-in-class weight loss, supported by a diversified GLP-1 pipeline spanning oral and injectable therapies.
Backed by top-tier investors and led by a proven CEO with major biotech exits, positioning the company for strong execution and potential long-term value creation.


Kailera Therapeutics (KLRA): Bain Backed Obesity Biotech Garners Significant Interest

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aevex Corp (AVEX US)

AEVEX Corp (AVEX): PE-Backed Defense Technology Company Sets Terms Seeking up to $2.35b Valuation

AEVEX Aerospace IPO offers 16M shares at $18-$21, backed by Madison Dearborn Partners with strong defense sector tailwinds driving investor demand.

IPO Boutique

Aevex Corp (AVEX): Peeking at the IPO Prospectus of a PE-Backed Defense Technology Company

AEVEX Aerospace's IPO filing highlights its strong presence in the defense and intelligence sectors, backed by Madison Dearborn Partners and...

IPO Boutique

HawkEye 360 Inc. (HAWK): Defense Technology Partner of USA Sets Terms for IPO

Hawkeye 360 to launch IPO at $24–$26, backed by top underwriters, with strong revenue growth and national security data platform potential.

IPO Boutique

Kailera Therapeutics (KLRA): Bain Backed Obesity Biotech Garners Significant Interest

Kailera Therapeutics IPO sees strong demand, with potential for pricing strength and long-term value creation driven by promising weight loss drug...

IPO Boutique

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

AEVEX Corp (AVEX): PE-Backed Defense Technology Company Sets Terms Seeking up to $2.35b Valuation

​AEVEX Aerospace IPO offers 16M shares at $18-$21, backed by Madison Dearborn Partners with strong defense sector tailwinds driving investor demand.

IPO Boutique

Aevex Corp (AVEX): Peeking at the IPO Prospectus of a PE-Backed Defense Technology Company

​AEVEX Aerospace's IPO filing highlights its strong presence in the defense and intelligence sectors, backed by Madison Dearborn Partners and...

IPO Boutique

HawkEye 360 Inc. (HAWK): Defense Technology Partner of USA Sets Terms for IPO

​Hawkeye 360 to launch IPO at $24–$26, backed by top underwriters, with strong revenue growth and national security data platform potential.

IPO Boutique

Kailera Therapeutics (KLRA): Bain Backed Obesity Biotech Garners Significant Interest

​Kailera Therapeutics IPO sees strong demand, with potential for pricing strength and long-term value creation driven by promising weight loss drug...

IPO Boutique

AEVEX Aerospace IPO offers 16M shares at $18-$21, backed by Madison Dearborn Partners with strong defense sector tailwinds driving investor demand.

AEVEX Aerospace's IPO filing highlights its strong presence in the defense and intelligence sectors, backed by Madison Dearborn Partners and...

Hawkeye 360 to launch IPO at $24–$26, backed by top underwriters, with strong revenue growth and national security data platform potential.

Kailera Therapeutics IPO sees strong demand, with potential for pricing strength and long-term value creation driven by promising weight loss drug...